EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein

Sara Lacerda iD, Robin M de Kruijff iD, Kristina Djanashvili iD

Molecules · 2025

DOI: 10.3390/molecules30061296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Sara Lacerda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, Rue Charles Sadron, 45071 Orléans, France. Hauptthemen laut MEDLINE: Click Chemistry, Alpha Particles, Radiopharmaceuticals, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent years have seen a swift rise in the use of α-emitting radionuclides such as 225Ac and 223Ra as various radiopharmaceuticals to treat (micro)metastasized tumors. They have shown remarkable effectiveness in clinical practice owing to the highly cytotoxic α-particles that are emitted, which have a very short range in tissue, causing mainly double-stranded DNA breaks. However, it is essential that both chelation and targeting strategies are optimized for their successful translation to clinical application, as α-emitting radionuclides have distinctly different features compared to β−-emitters, including their much larger atomic radius. Furthermore, upon α-decay, any daughter nuclide irrevocably breaks free from the targeting molecule, known as the recoil effect, dictating the need for faster targeting to prevent healthy tissue toxicity. In this review we provide a brief overview of the current status of targeted α-therapy and highlight innovations in α-emitter-based chelator design, focusing on the role of click chemistry to allow for fast complexation to biomolecules at mild labeling conditions. Finally, an outlook is provided on different targeting strategies and the role that pre-targeting can play in targeted alpha therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Click ChemistryAlpha ParticlesRadiopharmaceuticalsNeoplasmsHumansAnimalsChelating Agents

Stichwörter der Autor:innen

chelatorsclick chemistrycomplexationpre-targetingradionuclidesrecoiling daughterstargeted alpha therapytargeting vectorstumors

Substanzen

RadiopharmaceuticalsChelating Agents

Autor:innen und Institutionen

  • Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, Rue Charles Sadron, 45071 Orléans, France.
  • Department of Radiation Science and Technology, Delft University of Technology, Mekelweg 15, 2629 JB Delft, The Netherlands.
  • Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands.

ORCID-Profile: Sara Lacerda, Robin M de Kruijff, Kristina Djanashvili

Zitieren

APA

Lacerda, S., de Kruijff, R. M., & Djanashvili, K. (2025). The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein. Molecules. https://doi.org/10.3390/molecules30061296

Vancouver

Lacerda S, de Kruijff RM, Djanashvili K. The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein. Molecules. 2025. doi:10.3390/molecules30061296

BibTeX
@article{Lacerda2025,
  author = {Lacerda, Sara and de Kruijff, Robin M and Djanashvili, Kristina},
  title = {The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30061296}
}
Kostenlos starten →